Table 2. Pneumococcal vaccination coverages with PPsV23 and PCV13 by underlying risk conditions, Catalonia, Spain, 2017 (n = 2,057,656).
| Risk condition/factor | PPsV23 | PCV13 | ||
|---|---|---|---|---|
| n | % | n | % | |
| Chronic respiratory diseases | ||||
| Chronic bronchitis/emphysema (n = 132,306) | 96,453 | 72.9 | 2,859 | 2.2 |
| Asthma (n = 95,600) | 52,817 | 55.2 | 1,218 | 1.3 |
| Chronic heart diseases | ||||
| Congestive heart failure (n = 63,596) | 51,909 | 81.6 | 1,327 | 2.1 |
| Coronary artery disease (n = 117,575) | 81,491 | 69.3 | 715 | 0.6 |
| Diabetes mellitus (n = 350,511) | 242,214 | 69.1 | 4,179 | 1.2 |
| Chronic renal disease (n = 158,726) | 122,791 | 77.4 | 5633 | 3.5 |
| Cirrhosis (n = 7,957) | 4,576 | 57.5 | 294 | 3.7 |
| Cancer (n = 236,623) | 139,911 | 59.1 | 3,758 | 1.6 |
| Alcoholism (n = 64,829) | 22,992 | 35.5 | 492 | 0.7 |
| Smoking (n = 344,471) | 68,966 | 20.0 | 1,646 | 0.5 |
| Splenectomy (n = 362) | 190 | 52.5 | 92 | 25.4 |
PPsV23: 23-valent pneumococcal polysaccharide vaccine; PCV13: 13-valent pneumococcal conjugate vaccine.